Similar articles for PMID: 22145083

Year	Number of Results
1998	1
2001	1
2002	1
2004	2
2005	4
2006	2
2007	1
2008	3
2009	6
2010	4
2011	5
2012	7
2013	4
2014	3
2015	8
2016	6
2017	11
2018	8
2019	10
2020	5
2021	5
2024	0

1

Evidence for Elevated Cerebrospinal Fluid ERK1/2 Levels in Alzheimer Dementia.

Spitzer P, Schieb H, Kamrowski-Kruck H, Otto M, Chiasserini D, Parnetti L, Herukka SK, Schuchhardt J, Wiltfang J, Klafki HW. Spitzer P, et al. Int J Alzheimers Dis. 2011;2011:739847. doi: 10.4061/2011/739847. Epub 2011 Nov 24. Int J Alzheimers Dis. 2011. PMID: 22145083 Free PMC article.

2

Clinical Experience with Cerebrospinal Fluid Aβ42, Total and Phosphorylated Tau in the Evaluation of 1,016 Individuals for Suspected Dementia.

Tariciotti L, Casadei M, Honig LS, Teich AF, McKhann Ii GM, Tosto G, Mayeux R. Tariciotti L, et al. J Alzheimers Dis. 2018;65(4):1417-1425. doi: 10.3233/JAD-180548. J Alzheimers Dis. 2018. PMID: 30149454 Free PMC article.

3

Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand.

Thaweepoksomboon J, Senanarong V, Poungvarin N, Chakorn T, Siwasariyanon N, Washirutmangkur L, Udompunthuruk S. Thaweepoksomboon J, et al. J Med Assoc Thai. 2011 Feb;94 Suppl 1:S77-83. J Med Assoc Thai. 2011. PMID: 21721431

4

Addition of the Aβ42/40 ratio to the cerebrospinal fluid biomarker profile increases the predictive value for underlying Alzheimer's disease dementia in mild cognitive impairment.

Baldeiras I, Santana I, Leitão MJ, Gens H, Pascoal R, Tábuas-Pereira M, Beato-Coelho J, Duro D, Almeida MR, Oliveira CR. Baldeiras I, et al. Alzheimers Res Ther. 2018 Mar 20;10(1):33. doi: 10.1186/s13195-018-0362-2. Alzheimers Res Ther. 2018. PMID: 29558986 Free PMC article.

5

Cerebrospinal fluid tau and beta-amyloid 42 proteins identify Alzheimer disease in subjects with mild cognitive impairment.

Riemenschneider M, Lautenschlager N, Wagenpfeil S, Diehl J, Drzezga A, Kurz A. Riemenschneider M, et al. Arch Neurol. 2002 Nov;59(11):1729-34. doi: 10.1001/archneur.59.11.1729. Arch Neurol. 2002. PMID: 12433260

6

Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia.

Buchhave P, Minthon L, Zetterberg H, Wallin AK, Blennow K, Hansson O. Buchhave P, et al. Arch Gen Psychiatry. 2012 Jan;69(1):98-106. doi: 10.1001/archgenpsychiatry.2011.155. Arch Gen Psychiatry. 2012. PMID: 22213792

7

Discriminatory and predictive capabilities of enzyme-linked immunosorbent assay and multiplex platforms in a longitudinal Alzheimer's disease study.

Jongbloed W, Kester MI, van der Flier WM, Veerhuis R, Scheltens P, Blankenstein MA, Teunissen CE. Jongbloed W, et al. Alzheimers Dement. 2013 May;9(3):276-83. doi: 10.1016/j.jalz.2012.01.004. Epub 2012 Oct 27. Alzheimers Dement. 2013. PMID: 23110867

8

Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.

Lautner R, Palmqvist S, Mattsson N, Andreasson U, Wallin A, Pålsson E, Jakobsson J, Herukka SK, Owenius R, Olsson B, Hampel H, Rujescu D, Ewers M, Landén M, Minthon L, Blennow K, Zetterberg H, Hansson O; Alzheimer’s Disease Neuroimaging Initiative. Lautner R, et al. JAMA Psychiatry. 2014 Oct;71(10):1183-91. doi: 10.1001/jamapsychiatry.2014.1060. JAMA Psychiatry. 2014. PMID: 25162367

9

Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice.

Andreasen N, Minthon L, Davidsson P, Vanmechelen E, Vanderstichele H, Winblad B, Blennow K. Andreasen N, et al. Arch Neurol. 2001 Mar;58(3):373-9. doi: 10.1001/archneur.58.3.373. Arch Neurol. 2001. PMID: 11255440 Clinical Trial.

10

Cerebrospinal fluid profiles and prospective course and outcome in patients with amnestic mild cognitive impairment.

Okonkwo OC, Mielke MM, Griffith HR, Moghekar AR, O'Brien RJ, Shaw LM, Trojanowski JQ, Albert MS; Alzheimer's Disease Neuroimaging Initiative. Okonkwo OC, et al. Arch Neurol. 2011 Jan;68(1):113-9. doi: 10.1001/archneurol.2010.334. Arch Neurol. 2011. PMID: 21220682 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

87 results

Results by year